Humana (HUM) Liabilities and Shareholders Equity (2009 - 2026)

Humana (HUM) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $55.3 billion in Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 8.54% year-over-year to $55.3 billion in Q1 2026; TTM through Mar 2026 was $204.3 billion, a 3.42% increase from a year earlier, with the FY2025 full-year figure at $48.9 billion, up 5.23% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $55.3 billion, up from $48.9 billion in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for HUM reached as high as $56.5 billion in Q2 2023 and fell as low as $43.1 billion in Q4 2022.
• Historically, Liabilities and Shareholders Equity has averaged $50.2 billion across 5 years, with a median of $50.1 billion in 2024.
• Across the five-year window, Liabilities and Shareholders Equity climbed 23.77% in 2022 and dropped 11.27% in 2024, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $43.1 billion in 2022, then advanced by 9.31% to $47.1 billion in 2023, then decreased by 1.25% to $46.5 billion in 2024, then rose by 5.23% to $48.9 billion in 2025, then gained by 13.03% to $55.3 billion in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $55.3 billion in Q1 2026, $48.9 billion in Q4 2025, and $49.7 billion in Q3 2025.